BORGO, CHRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 2.860
EU - Europa 395
AS - Asia 267
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.524
Nazione #
US - Stati Uniti d'America 2.860
CN - Cina 214
IT - Italia 163
SE - Svezia 86
FI - Finlandia 61
VN - Vietnam 39
DE - Germania 28
UA - Ucraina 17
GB - Regno Unito 15
FR - Francia 11
IN - India 9
IE - Irlanda 8
BG - Bulgaria 3
KR - Corea 3
ES - Italia 2
TR - Turchia 2
EU - Europa 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 3.524
Città #
Fairfield 514
Woodbridge 324
Chandler 292
Ashburn 242
Houston 212
Seattle 208
Wilmington 197
Cambridge 181
Ann Arbor 144
Padova 61
Des Moines 47
Beijing 46
Princeton 45
Jacksonville 43
Helsinki 41
Medford 41
San Diego 40
Dong Ket 39
Nanjing 31
New York 21
Boardman 20
Roxbury 18
Cagliari 15
Shenyang 15
Guangzhou 14
Jinan 14
Los Angeles 13
Nanchang 11
Dublin 8
Ningbo 8
Tianjin 8
Milan 7
Falls Church 6
Hebei 6
Kharkiv 6
Changsha 5
Fuzhou 4
Hefei 4
Vicenza 4
Bupyeong-gu 3
Dearborn 3
Haikou 3
Kunming 3
Lanzhou 3
Livorno 3
Munich 3
Norwalk 3
Perugia 3
Redwood City 3
Sofia 3
Taizhou 3
Venice 3
Albignasego 2
Aprilia 2
Arbus 2
Bologna 2
Buffalo 2
Campodarsego 2
Chengdu 2
Fort Worth 2
Genoa 2
Hangzhou 2
Istanbul 2
Lappeenranta 2
New Bedfont 2
Ogden 2
Paris 2
Pasiano 2
Reggio Emilia 2
Sherman Oaks 2
Tappahannock 2
Xian 2
Zhengzhou 2
Arezzo 1
Auburn Hills 1
Avigliano 1
Belluno 1
Boydton 1
Cardiff 1
Chiswick 1
Chongqing 1
Christchurch 1
Corpus Christi 1
Enna 1
Falkenstein 1
Florence 1
Foggia 1
Fontanelle 1
Frankfurt am Main 1
Gazzo 1
Gunzenhausen 1
Hanover 1
Horia 1
Indiana 1
Islington 1
Jiaxing 1
Lviv 1
Mariano Comense 1
Mestrino 1
Montecatini Terme 1
Totale 3.063
Nome #
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity 189
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127. 156
A proteomics analysis of CK2β(-/-) C2C12 cells provides novel insights into the biological functions of the non-catalytic β subunit 150
Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells 147
A journey through the cytoskeleton with protein kinase CK2 145
CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3 (-) exchange in human airway epithelia 142
Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity 132
Protein kinase CK2 is involved in adipose tissue insulin signaling and remodeling during obesity and weight loss 126
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells. Biochemical evidence and therapeutic perspectives 117
Dependence of HSP27 cellular level on protein kinase CK2 discloses novel therapeutic strategies 115
null 105
Exploring the CK2 paradox: Restless, dangerous, dispensable 102
Role of protein kinase CK2 in antitumor drug resistance 98
Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells 92
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells 86
The protein kinase CK2 contributes to the protumorigenic properties of cholangiocarcinoma cells 84
Synthesis and Evaluation of Platelet Aggregation Inhibitory Activity of Some 3-Phenyl-pyrroloquinazolinones 81
Coinvolgimento della proteinchinasi CK2 nella resistenza all’imatinib in cellule di leucemia mieloide cronica 79
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 71
Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells 71
A N-terminally deleted form of the CK2 alpha' catalytic subunit is sufficient to support cell viability 71
null 68
“Janus” efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms 67
null 66
Protein kinase CK2 inhibition as a pharmacological strategy 66
White adipose tissue expansion in multiple symmetric lipomatosis is associated with upregulation of ck2, akt and erk1/2 63
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR 61
Protein kinase CK2 subunits differentially perturb the adhesion and migration of GN11 cells: A model of immature migrating neurons 57
Aberrant Signalling by Protein Kinase CK2 in Imatinib-resistant Chronic Myeloid Laeukemia Cells 56
J-SUBUNIT OF THE EUKARYOTIC INITIATION FACTOR 3 IS A NEW SUBSTRATE OF PROTEIN KINASE CK2 55
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach 55
Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells 50
Protein kinase CK2: a new target to overcome imatinib-resistance in CML cells 48
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance 47
Coinvolgimento della proteinchinasi CK2 nella resistenza all'imatinib in cellule di leucemia mieloide cronica 47
HOW PROTEIN KINASE CK2 IS INVOLVED IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA CELLS? 46
Targeting protein kinase CK2 to overcome imatinib-resitance 37
INVOLVEMENT OF THE PROTEIN KINASE CK2 AND ITS INTERACTOME IN IMATINIB SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA CELLS 36
How can a traffic light properly work if it is always green? The paradox of CK2 signaling 36
Protein kinase CK2: a potential therapeutic target for diverse human diseases 35
Transport of serotonin into human platelets is regulated by tyrosinephosphorylation of SERT and its interaction with integrin-alphaII/beta3 34
Modulation of protein kinases in the regulation of chaperone machinery leading F508-del-CFTR fate - The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis 33
A mutational approach to dissect the functional role of the putative CFTR “PTM-CODE” 32
Involvement of Protein Kinase CK2 in Imatinib-resistant Chronic Myeloid Leukemia Cells 31
Regulation of serotonin transport in human platelets by tyrosine kinase Syk 21
The protein kinase ck2 associates with and phosphorylates the eukaryotic initiation factor 3 20
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants 18
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells 15
Targeting CK2 in cancer: a valuable strategy or a waste of time? 13
Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate 12
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR 12
null 8
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant 3
Totale 3.607
Categoria #
all - tutte 13.264
article - articoli 11.737
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019191 0 0 0 0 0 0 0 0 0 0 95 96
2019/2020809 62 35 15 99 80 46 96 94 91 105 59 27
2020/2021805 39 30 73 47 46 31 66 43 94 155 72 109
2021/2022672 18 66 71 70 50 54 24 52 36 27 65 139
2022/2023537 84 79 6 70 82 75 5 29 55 6 30 16
2023/2024272 21 46 38 25 38 27 21 30 8 16 2 0
Totale 3.607